BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28005422)

  • 1. Multilevel, Dynamic Chronic Obstructive Pulmonary Disease Heterogeneity. A Challenge for Personalized Medicine.
    Faner R; Agustí Á
    Ann Am Thorac Soc; 2016 Dec; 13 Suppl 2():S466-S470. PubMed ID: 28005422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypes and disease characterization in chronic obstructive pulmonary disease. Toward the extinction of phenotypes?
    Agustí A
    Ann Am Thorac Soc; 2013 Dec; 10 Suppl():S125-30. PubMed ID: 24313762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The objective evaluation of obstructive pulmonary diseases with spirometry.
    Ozkaya S; Dirican A; Tuna T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Challenges of Precision Medicine in COPD.
    Cazzola M; Calzetta L; Rogliani P; Matera MG
    Mol Diagn Ther; 2017 Aug; 21(4):345-355. PubMed ID: 28247183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postural abnormalities in phenotypes of chronic obstructive pulmonary disease.
    Muhammed A; Moiz JA; Singla D; Ali MS; Talwar D
    Braz J Phys Ther; 2020; 24(4):325-332. PubMed ID: 31151892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [COPD diagnosis in the practice. Can the peak-flow-meter replace spirometry?].
    Petro W
    MMW Fortschr Med; 2004 Mar; 146(11):10. PubMed ID: 15152757
    [No Abstract]   [Full Text] [Related]  

  • 7. Biomarkers, the control panel and personalized COPD medicine.
    Agusti A; Gea J; Faner R
    Respirology; 2016 Jan; 21(1):24-33. PubMed ID: 26172306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized medicine and chronic obstructive pulmonary disease.
    Wouters EF; Wouters BB; Augustin IM; Franssen FM
    Curr Opin Pulm Med; 2017 May; 23(3):241-246. PubMed ID: 28257315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study.
    Calle Rubio M; Casamor R; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2373-2383. PubMed ID: 28848338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phenotype specific therapy of COPD].
    Rothe T
    Praxis (Bern 1994); 2014 Dec; 103(25):1509-14. PubMed ID: 25491053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of chronic bronchitic, emphysematous and ACOS phenotypes in COPD patients with frequent exacerbations.
    Cheng Y; Tu X; Pan L; Lu S; Xing M; Li L; Chen X
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2069-2074. PubMed ID: 28790809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Airway distensibility and volume recruitment with lung inflation in COPD.
    Baldi S; Dellacà R; Govoni L; Torchio R; Aliverti A; Pompilio P; Corda L; Tantucci C; Gulotta C; Brusasco V; Pellegrino R
    J Appl Physiol (1985); 2010 Oct; 109(4):1019-26. PubMed ID: 20651219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic obstructive pulmonary disease subpopulations and phenotyping.
    Segal LN; Martinez FJ
    J Allergy Clin Immunol; 2018 Jun; 141(6):1961-1971. PubMed ID: 29884286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tidal expiratory flow limitation at rest as a functional marker of pulmonary emphysema in moderate-to-severe COPD.
    Chiari S; Bassini S; Braghini A; Corda L; Boni E; Tantucci C
    COPD; 2014 Feb; 11(1):33-8. PubMed ID: 24102405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype/endotype-driven therapy in COPD: potential economic implications.
    Antoniu SA
    Expert Rev Pharmacoecon Outcomes Res; 2013 Aug; 13(4):421-3. PubMed ID: 23977968
    [No Abstract]   [Full Text] [Related]  

  • 16. The Promise of Observational Studies (ECLIPSE, SPIROMICS, and COPDGene) in Achieving the Goal of Personalized Treatment of Chronic Obstructive Pulmonary Disease.
    Rennard SI
    Semin Respir Crit Care Med; 2015 Aug; 36(4):478-90. PubMed ID: 26238636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic obstructive pulmonary disease: nature-nurture interactions.
    Clancy J; Nobes M
    Br J Nurs; 2012 Jul 12-25; 21(13):772-81. PubMed ID: 22874776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COPD evaluation: back to the future.
    Izquierdo Alonso JL
    Arch Bronconeumol; 2010 Feb; 46(2):53-5. PubMed ID: 20092931
    [No Abstract]   [Full Text] [Related]  

  • 19. Multidetector computed tomographic imaging in chronic obstructive pulmonary disease: emphysema and airways assessment.
    Litmanovich DE; Hartwick K; Silva M; Bankier AA
    Radiol Clin North Am; 2014 Jan; 52(1):137-54. PubMed ID: 24267715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker Development for Chronic Obstructive Pulmonary Disease. From Discovery to Clinical Implementation.
    Sin DD; Hollander Z; DeMarco ML; McManus BM; Ng RT
    Am J Respir Crit Care Med; 2015 Nov; 192(10):1162-70. PubMed ID: 26176936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.